In June 2016, Program for Accessible Health Communication and Education (PACE) Contracted Socio-Economic Data Centre Ltd (SEDC) to conduct a Misoprostol Landscape Analysis to support efforts to grow the Misoprostol market to match the unmet need for prevention of PPH and abortion-related deaths. This exercise was viewed as a critical step in the Total Market Approach process that would inform analysis and decision making for market development interventions for Misoprostol.

PROJECT TITLE

Misoprostol Market Landscape – Uganda


Client

PACE

Services

Needs Assessments

Sector

Health and Wellbeing

Date started

2016-11

Lead consultant

Prof. Narathius Asingwire


PURPOSE

To compile a market landscape for Misoprostol products in Uganda in order to inform the analysis and decision-making for market development interventions for the drug.


OBJECTIVES / QUESTIONS

1. To examine the functions, players, relationships and incentives within the Misoprostol market in Uganda.
2. To prepare the Production to Use Spectrum for Misoprostol
3. To identify key market failures and constraints faced by Misoprostol markets in Uganda
4. To establish the import volume and value of Miso per year and therefore PACE market share
5. To understand market trends that are likely to influence the availability and distribution of Misoprostol


METHODOLOGY

This Market Landscape adopted an exploratory design. Data was collected mainly through two approaches, namely literature review and key informant interviews. A wide range of documents including reports, drug catalogues in warehouses, procurement records and data records were reviewed. Through document review information on some of the existing players in the market, their functions and regulations governing the market was gathered. Key informant interviews were organized with the players identified to obtain a deeper understanding of the market, particularly how it is failing the end consumer. Information on volumes imported, stock of Misoprostol available, sources of funding for players in the public sector, private not for profit including Social Marketing Organizations and the commercial sector was obtained. Policy makers and the regulatory body were also reached to understand the facilitators and barriers to Misoprostol use and availability in those areas, from their perspective.


PROJECT ATTACHMENTS